Ar
Lama Alsamnan, OD
Pediatric Optometry Specialist
King Abdullah Specialized Children’s Hospital-National Guard Health Affairs
The Refractive Error Landscape in the Kingdom
From Correction of Vision… to Advanced Vision Management
In pediatric optometry clinics, a recurring pattern emerges: a child presents with mild myopia at initial visit, returns the following year with a stronger prescription requirement, and this cycle continues. For an extended period, the optometrist’s role concluded at prescribing spectacles. That fundamental paradigm has now transformed.
Myopia is no longer regarded as a simple refractive error. It represents a structural condition characterized by axial elongation of the eye, with potential serious long-term consequences including retinal detachment and glaucoma when high myopia develops. This reframes myopia management not merely as an optional specialty service, but as an essential clinical imperative.
The Clinical Landscape
From Prescription Correction… to Disease Management
In pediatric optometry practices, the clinical reality is straightforward: a child returns annually for routine refraction testing, receives an updated prescription, and continues this pattern. While axial length measurement provides precise anatomical assessment, the underlying biological progression, the axis lengthening that drives refractive error remains the critical variable to address.
“In the Kingdom, myopia prevalence differs by age bracket and geographic region. While epidemiological data shows variation across different age cohorts, the rates are notably increasing, with some regions reporting escalation through secondary school and into university enrollment periods”.
The encouraging reality is that optometrists across the Kingdom have demonstrated professional sophistication: comprehensive initial screening, systematic family counseling, organized follow-up schedules, and progressive implementation of advanced measurement tools. However, the success of this clinical ecosystem remains dependent on access to a diverse, comprehensive range of treatment modalities.
Market Transformation .. What Changed in 2025?
2025 – A Year of Transformation
Following years of limited therapeutic options, 2025 marks a watershed moment in the Kingdom’s myopia management landscape. Historically, practitioners had access to atropine eye drops and myopia control spectacle lenses exclusively. In 2025, this landscape has expanded significantly with the introduction of specialized myopia control contact lenses and repeated low-level red light therapy technologies both now available in the Saudi market for the first time, completing a genuinely comprehensive multi-modal therapeutic toolkit.
